1. Stampfer MJ, Malinow R, Willett WC, et al. A prospective study of
plasma homocysteine and risk of myocardial infarction in US physicians. JAMA
2. Bostom AG, Silbershatz H, Rosenberg IH, et al. Nonfasting plasma total
homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham
men and women. Arch Intern Med 1999;159:1077–80.
3. Folsom AR, Nieto J, McGovern PG, et al. Prospective study of coronary
heart disease incidence in relation to fasting total homocysteine, related genetic
polymorphisms, and B vitamins. Circulation 1998;98:204–10.
4. Kuller LH, Evans RW. Homocysteine, vitamins, and cardiovascular
disease. Circulation 1998;98:196–9 [editorial].
5. Christen WG, Ajani UA, Glynn RJ, Hennekens CH. Blood levels of
homocysteine and increased risks of cardiovascular disease. Arch Intern Med
6. Meleady R, Graham I. Plasma homocysteine as a cardiovascular risk
factor: causal, consequential, or of no consequence? Nutr Rev 1999;57:299–305
7. Williams JE, Paton CC, Siegler IC, et al. Anger proneness predicts
coronary heart disease risk: prospective analysis from the atherosclerosis risk in communities
(ARIC) study. Circulation 2000;101:2034–9.
8. Kawachi I, Sparrow D, Spiro A 3rd, et al. A prospective study of anger
and coronary heart disease. The Normative Aging Study. Circulation
9. Stoney CM, Engebretson TO. Plasma homocysteine concentrations are
positively associated with hostility and anger. Life Sci 2000;66:2267–75.
10. Perry IJ, Refsum H, Morris RW, et al. Prospective study of serum
total homocysteine concentration and risk of stroke in middle-aged British men.
11. Langman LJ, Ray JG, Evrovski J, et al. Hyperhomocyst(e)inemia and the
increased risk of venous thromboembolism: more evidence from a case-control study. Arch
Intern Med 2000;160:961–4.
12. Brattstrom LE, Hultberg BL, Hardebo JE. Folic acid responsive
postmenopausal homocysteinemia. Metabolism 1985;34:1073–7.
13. Cattaneo M, Vecchi M, Zighetti ML, et al. High prevalence of
hyperhomocysteinemia in patients with inflammatory bowel disease: a pathogenic link with
thromboembolic complications? Thromb Haemost 1998;80:542–5.
14. Clarke R, Smith D, Jobst KA, et al. Folate, vitamin B12, and serum
total homocysteine levels in confirmed Alzheimer disease. Arch Neruol
15. Hoogeveen EK, Kostense PJ, Jakobs C, et al. Hyperhomocysteinemia
increases risk of death, especially in type 2 diabetes : 5-year follow-up of the Hoorn Study.
16. Sutterlin M, Bussen S, Ruppert D, Steck T. Serum levels of folate and
cobalamin in women with recurrent spontaneous abortion. Hum Reprod
17. Wouters MG, Boers GH, Blom HJ, et al. Hyperhomocysteinemia: a risk
factor in women with unexplained recurrent early pregnancy loss. Fertil Steril
18. Steegers-Theunissen RP, Boers GH, Blom HJ, et al.
Hyperhomocysteinaemia and recurrent spontaneous abortion or abruptio placentae.
Lancet 1992;339:1122–3 [letter].
19. Quere I, Bellet H, Hoffet M, et al. A woman with five consecutive
fetal deaths: case report and retrospective analysis of hyperhomocysteinemia prevalence in 100
consecutive women with recurrent miscarriages. Fertil Steril 1998;69:152–4.
20. Nelen WL, Blom HJ, Steegers EA, et al. Homocysteine and folate levels
as risk factors for recurrent early pregnancy loss. Obstet Gynecol
21. de Vries JI, Dekker GA, Huijgens PC, et al. Hyperhomocysteinaemia and
protein S deficiency in complicated pregnancies. Br J Obstet Gynaecol
22. Goddijn-Wessel TA, Wouters MG, van de Molen EF, et al.
Hyperhomocysteinemia: a risk factor for placental abruption or infarction. Eur J Obstet
Gynecol Reprod Biol 1996;66:23–9.
23. Leeda M, Riyazi N, de Vries JI, et al. Effects of folic acid and
vitamin B6 supplementation on women with hyperhomocysteinemia and a history of preeclampsia or
fetal growth restriction. Am J Obstet Gynecol 1998;179:135–9.
24. Dekker GA, de Vries JI, Doelitzsch PM, et al. Underlying disorders
associated with severe early-onset preeclampsia. Am J Obstet Gynecol
25. Rajkovic A, Catalano PM, Malinow MR. Elevated homocyst(e)ine levels
with preeclampsia. Obstet Gynecol 1997;90:168–71.
26. Catargi B, Parrot-Roulaud F, Cochet C, et al. Homocysteine,
hypothyroidism, and effect of thyroid hormone replacement. Thyroid
27. Boers GHJ, Smals AGH, Trijbels FJM, et al. Heterozygosity for
homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J
28. Broekmans WM, Klopping-Ketelaars IA, Schuurman CR, et al. Fruits and
vegetables increase plasma carotenoids and vitamins and decrease homocysteine in humans. J
29. Jang Y, Lee JH, Kim OY, et al. Consumption of whole grain and legume
powder reduces insulin demand, lipid peroxidation, and plasma homocysteine concentrations in
patients with coronary artery disease: randomized controlled clinical trial. Arterioscler
Thromb Vasc Biol 2001;21:2065–71.
30. Nygård O, Refsum H, Ueland PM, Vollset SE. Major lifestyle
determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study.
Am J Clin Nutr 1998;67:263–70.
31. Stolzenberg-Solomon RZ, Miller ER 3rd, Maguire MG, et al. Association
of dietary protein intake and coffee consumption with serum homocysteine concentrations in an
older population. Am J Clin Nutr 1999;69:467–75.
32. Nieto FJ, Comstock GW, Chambless LE, Malinow RM. Coffee consumption
and plasma homocyst(e)ine: results from the Atherosclerosis Risk in Communities Study. Am
J Clin Nutr 1997;66:1475–85 [letter].
33. DeRose DJ, Charles-Marcel ZL, Jamison JM, et al. Vegan diet-based
lifestyle program rapidly lowers homocysteine levels. Prev Med
34. Glueck CJ, Shaw P, Land JE, et al. Evidence that homocysteine is an
independent risk factor for atherosclerosis in hyperlipidemic patients. Am J Cardiol
35. Ubbink JB, Vermaak WJH, van der Merwe A, Becker PJ. Vitamin B12,
vitamin B6, and folate nutritional status in men with hyperhomocysteinemia. Am J Clin
36. Ubbink JB, Vermaak WJH, ven der Merwe A, et al. Vitamin requirements
for the treatment of hyperhomocysteinemia in humans. J Nutr
37. Dierkes J, Kroesen M, Pietrzik K. Folic acid and vitamin B6
supplementation and plasma homocysteine concentrations in healthy young women. Int J Vitam
Nutr Res 1998;68:98–103.
38. Stein JH, McBride PE. Hyperhomocysteinemia and atherosclerotic
vascular disease: pathophysiology, screening, and treatment. Arch Intern Med
39. McGregor D, Shand B, Lynn K. A controlled trial of the effect of
folate supplements on homocysteine, lipids and hemorheology in end-stage renal disease.
40. Food standards: amendment of standards of identity for enriched grain
products to require addition of folic acid. Fed Regist 1996;61:8781–97.
41. Jacques PF, Selhub J, Bostom AG, et al. The effect of folic acid
fortification on plasma folate and total homocysteine concentrations. N Engl J Med
42. Malinow MR, Duell PB, Hess DL, et al. Reduction of plasma
homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary
heart disease. N Engl J Med 1998;338:1009–15.
43. McNulty H, Dowey LR, Strain JJ, et al. Riboflavin lowers homocysteine
in individuals homozygous for the MTHFR 677Cà T polymorphism. Circulation
44. Wilcken DEL, Wilcken B, Dudman NP, Tyrrell PA.
Homocystinuria—the effects of betaine in the treatment of patients not responsive to
pyridoxine. N Engl J Med 1983;309:448–53.
45. Jancin B. Amino acid defect causes 20% of atherosclerosis in CHD.
Fam Pract News 1994(Oct 15):7.
46. Olthof MR, Brink EJ, Katan MB, Verhoef P. Choline supplemented as
phosphatidylcholine decreases fasting and postmethionine-loading plasma homocysteine
concentrations in healthy men. Am J Clin Nutr 2005;82:111–7.
47. Olthof MR, van Vliet T, Boelsma E, Verhoef P. Low dose betaine
supplementation leads to immediate and long term lowering of plasma homocysteine in healthy
men and women. J Nutr 2003;133:4135–8.
48. Garg R, Malinow M, Pettinger M, et al. Niacin treatment increases
plasma homocyst(e)ine levels. Am Heart J 1999;138:1082–7.
49. Brown WV. Niacin for lipid disorders. Postgrad Med
50. Guyton JR. Effect of niacin on atherosclerotic cardiovascular
disease. Am J Cardiol 1998;82(12A):18U–23U [review].